Cancer hope for arthritis drug.
Celecoxib reduced the likelihood of pre-cancerous abnormal cells generating non-melanoma skin tumours.
The drug, marketed in the UK under the name Celebrex, is a non-steroidal anti-inflammatory drug (NSAID). It targets the enzyme cyclo-oxygenase 2 which is believed to be involved in the development of nonmelanoma skin cancers triggered by too much sun exposure. Four years ago the drug was at the centre of controversy after research suggested it might increase the risk of heart attacks and strokes.
Celecoxib belongs to the same drug family as Vioxx, withdrawn from the market following similar concerns.
|Printer friendly Cite/link Email Feedback|
|Publication:||Coventry Evening Telegraph (England)|
|Date:||Nov 30, 2010|
|Previous Article:||SCHOOLS PROTEST OVER SPORTS CUTS.|
|Next Article:||COMMUNITY ORDER FOR BIRD TRAPPER.|